Kurt Schnecker

USPTO Granted Patents = 9 (Patent Applications = 3)

CIPO Patents = 1

EPO Patents = 3 (Patent Applications = 6)

Average Co-Inventor Count = 4.1

ph-index = 4

Forward Citations = 39(Granted Patents)

Company Filing History:

4 out of 2,483

Baxter International Inc.

Takeda Pharmaceutical Company Limited

Boehringer Ingelheim International Gmbh

patents

where one patent can have more than one assignee

Years Active: 1993-2021

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11197916 - Lyophilized recombinant VWF formulations (2021-12-14),

2. 11191837 - Recombinant VWF formulations (2021-12-07),

3. 11191813 - Lyophilized recombinant VWF formulations (2021-12-07),

4. 10232022 - Lyophilized recombinant VWF formulations (2019-03-19),

5. 8454833 - Counter-pressure filtration of proteins (2013-06-04),

6. 8075782 - Counter-pressure filtration of proteins (2011-12-13),

7. 8075781 - Counter-pressure filtration of proteins (2011-12-13),

8. 7959809 - Counter-pressure filtration of proteins (2011-06-14),

9. 5266310 - Stabilization of therapeutically active proteins in pharmaceutical (1993-11-30),

Title: Kurt Schnecker: Innovator in Pharmaceutical Formulations

Introduction

Kurt Schnecker is a notable inventor based in Vienna, Austria, recognized for his contributions to the field of pharmaceutical formulations. With a total of nine patents to his name, he has made significant advancements in the development of stable pharmaceutical products.

Latest Patents

Among his latest patents, Kurt has developed lyophilized recombinant von-Willebrand Factor (rVWF) formulations. These long-term stable pharmaceutical formulations are designed for the effective administration of rVWF, showcasing innovative methods for their production and use.

Career Highlights

Kurt has had a distinguished career, working with prominent companies such as Baxter International Inc. and Baxter Healthcare S.A. His experience in these organizations has allowed him to refine his expertise in pharmaceutical innovations.

Collaborations

Throughout his career, Kurt has collaborated with esteemed colleagues, including Peter Turecek and Nebojsa Nikolic. These partnerships have contributed to the advancement of his research and the successful development of his patented formulations.

Conclusion

Kurt Schnecker's work in the field of pharmaceutical formulations exemplifies his dedication to innovation and improvement in healthcare solutions. His contributions continue to impact the industry positively.

This text is generated by artificial intelligence and may not be accurate.